The Treatment of Type 1 and Type 2 Diabetes Treating and managing type 1 or type 2 diabetes can involve multiple lifestyle habit changes, medications, and technology, and there is a great deal of overlap between the two conditions
New lapse risks The use of AOMs introduces the risk of anti-selective policyholder behavior, as individuals who have lost considerable weight may lapse their rated policies and re-enter with better terms
R., Wong, C., Hackam, D
Because it engages an additional glucagon pathway beyond dual-agonist compounds, retatrutide is frequently studied alongside Semaglutide (a mono-agonist) and Tirzepatide (a dual-agonist) to compare multi-receptor pharmacology
Semaglutide Dosing Semaglutide also follows a weekly injection protocol , but with a slightly different titration process: Starting dose: 0.25 mg weekly (for 4 weeks) Titrated to 0.5 mg weekly , then 1 mg weekly For obesity (Wegovy), doses can be escalated to 2.4 mg weekly Rybelsus offers a daily oral tablet option (7 mg or 14 mg), though weight loss outcomes are not as pronounced as with the injectable formulations Injection vs Oral Options The availability of oral Semaglutide (Rybelsus) makes it unique, particularly for individuals who prefer not to self-inject
